Abstract
The series of Mannich bases and one group of related α-aminoketones which had either 1 or 2 sites for thiol alkylation were evaluated against the WiDr tumour in vitro. Maximum activity was found in the bis alkylating agents (12–64 times the activity of the reference compound, 5-fluorouracil) and one of these bis Mannich bases had confirmed activity against murine P388 lymphocytic leukemia. No correlations were found with either the rate of alkylation with glutathione or the apparent partition coefficients of selected compounds with activity against the WiDr tumour in vitro.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.